Acquisition of non-branded medication(s) not covered by a price registration form, for patient care in compliance with a court order.

This tender, issued by the SECRETARIA DE ESTADO DA SAUDE (State Health Secretariat) for the ESP-DEPTO.REG.SAUDE - DRS-X PIRACICABA unit in Piracicaba, São Paulo, concerns the acquisition of specific medication(s). These medications are not branded and are not currently listed on any existing price registration forms. The procurement is being conducted to fulfill a court-ordered requirement for patient treatment. The modality is an Electronic Auction (Pregão Eletrônico), operating under an open bidding mode. This process is governed by Law 14.133/2021, specifically Article 28, item I, which mandates auctions for the procurement of common goods and services. The tender number is 90148, and the associated process number is 024.00146453/2025. Interested parties can access clarification and challenge responses via the provided link: https://cnetmobile.estaleiro.serpro.gov.br/comprasnet-web/public/landing?destino=quadro-informativo&compra=09013205901482025. The proposal submission period opens on March 2, 2026, at 08:00, and closes on March 12, 2026, at 09:00. This procurement is critical for ensuring timely access to necessary treatments for patients as mandated by judicial decisions.

This is a supplies contract in the legal services, health and medical services and information and communication technology sectors, with a focus on Pharmaceuticals. Located in Brazil, Latin America, this opportunity is open to firms and consortiums.

Published through Brazil PNCP, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the legal services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.